J&J Bows Out of Race for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:January 25, 2018 Post category:BioPharma Now insiders say J&J has decided it is no longer interested. Source: BioSpace You Might Also Like Debt-Ridden Valeant Dumps Another Asset in $190 Million Cash Deal July 16, 2017 Siemens Summons Three Banks for IPO of Healthineers Unit October 25, 2017 Arkis Biosciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire Technology April 19, 2017
Arkis Biosciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire Technology April 19, 2017
